UTERINE CORPUS LEIOMYOMA

Clinical trials for UTERINE CORPUS LEIOMYOMA explained in plain language.

Never miss a new study

Get alerted when new UTERINE CORPUS LEIOMYOMA trials appear

Sign up with your email to follow new studies for UTERINE CORPUS LEIOMYOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Old drug, new hope: mercaptopurine tested against rare cancer syndrome

Disease control Not yet recruiting

This trial tests the drug mercaptopurine in people with hereditary leiomyomatosis and renal cell carcinoma (HLRCC), a rare genetic condition that raises the risk of skin, uterine, and kidney tumors. The study aims to find the safest dose and see if the drug can shrink kidney canc…

Matched conditions: UTERINE CORPUS LEIOMYOMA

Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control

Last updated Jul 23, 2026 00:00 UTC

UTERINE CORPUS LEIOMYOMA

Get alerted when new UTERINE CORPUS LEIOMYOMA trials appear

Old drug, new hope: mercaptopurine tested against rare cancer syndrome